Nasal HFOV versus nasal IPPV as a post-extubation respiratory support in preterm infants —a randomised controlled trial
Conclusion: Extubation failure within 72 h in infants less than 37 weeks of gestation did not differ between the two groups. However, nHFOV seems promising in reducing enteral feeding issues and pCO2 elimination. Larger multicentre studies are required for exploring benefits of nHFOV.Trial registration:www.ctri.nic.in id CTRI/2019/07/020055, registration date July 5, 2019What is Known:• NIPPV is superior to nCPAP as a secondary mode of respiratory support.• Synchronisation is preferred for optimum ventilation.What is New:• nHFOV, a novel non-invasive respiratory modality without need for synchronisation, appears promising as a secondary mode subject to further trials.• It seems promising in reducing enteral feeding issues and pCO2 elimination.
Source: European Journal of Pediatrics - Category: Pediatrics Source Type: research